Media & news

The shareholders of Kinnevik AB (publ) ("Kinnevik") are hereby invited to an Extraordinary General Meeting to be held on Tuesday 10 December 2024 at 10:00 a.m. CET at Hotel At Six, Brunkebergstorg 6 in Stockholm. Registration for the Extraordinary General Meeting will commence at 9:30 a.m. CET. The Board has decided that the shareholders also shall be able to exercise their voting rights at the Extraordinary General Meeting by postal voting in advance.

Kinnevik AB (publ) ("Kinnevik") today announced that it has been informed that the Chair of the Board James Anderson has decided not to stand for re-election to the Kinnevik Board at the 2025 Annual General Meeting, and that the Nomination Committee proposes that an Extraordinary General Meeting to be held on 10 December 2024 resolves to elect Hans Ploos van Amstel and Jan Berntsson as new members of the Board for the period until the end of the next Annual General Meeting.

Kinnevik AB (publ) ("Kinnevik") today announced that as of 31 October 2024 the total number of shares in the company amounts to 283,590,320, and the total number of votes in the company amounts to 587,389,208.

"After seven years, the transformation to growth is completed. We enter the next phase of Kinnevik with a strong financial position, and with a growth-focused portfolio consisting of a high-performing core and several exciting earlier stage companies with the potential to create significant outcomes. During the quarter, we continued to execute on our strategic priorities, investing more capital into our core company Spring Health and our newer venture Aira. Valuations in the core companies grew on the back of strong growth and improving margins, but a full write-down of our remaining VillageMD investment and the weaker dollar weighed on our Net Asset Value.”